| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.29▼ | 2.27▲ | 2.23▲ | 1.99▲ | 1.90▲ |
| MA10 | 2.30▼ | 2.20▲ | 2.14▲ | 1.91▲ | 2.14▲ |
| MA20 | 2.28▲ | 2.11▲ | 2.05▲ | 1.88▲ | 2.55▼ |
| MA50 | 2.20▲ | 1.99▲ | 1.92▲ | 2.24▲ | 2.63▼ |
| MA100 | 2.12▲ | 1.91▲ | 1.88▲ | 2.72▼ | 4.18▼ |
| MA200 | 2.04▲ | 1.86▲ | 1.97▲ | 2.66▼ | 8.19▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | 0.017▲ | 0.028▲ | 0.065▲ | -0.060▼ |
| RSI | 55.755▲ | 75.175▲ | 76.364▲ | 60.110▲ | 47.204▼ |
| STOCH | 34.556 | 92.637▲ | 83.633▲ | 71.439 | 24.703 |
| WILL %R | -61.111 | -15.942▲ | -13.924▲ | -10.769▲ | -50.465 |
| CCI | -29.851 | 107.092▲ | 132.505▲ | 278.986▲ | -17.828 |
|
Sunday, April 26, 2026 01:24 PM
Following the successful spin-off of its Sandoz generics division in late 2023, Novartis AG (NYSE:NVS) has transformed into a high-margin, pure-play innovative medicines company that is currently ...
|
|
Friday, April 24, 2026 05:46 AM
Novartis (NYSE:NVS) said the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a favourable opinion recommending approval of Itvisma, an intrathecal gene therapy ...
|
|
Wednesday, December 10, 2025 11:06 PM
Swiss pharmaceutical giant Novartis AG (NYSE:NVS) has entered into a massive $1.7 billion partnership with British pharmaceutical firm Relation Therapeutics to develop treatments for allergic diseases ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/05/26 | 2.00 | 2.35 | 2.00 | 2.28 | 1,925,076 |
| 01/05/26 | 2.01 | 2.02 | 1.94 | 2.00 | 701,280 |
| 30/04/26 | 1.94 | 1.9999 | 1.86 | 1.97 | 1,098,120 |
| 29/04/26 | 1.90 | 1.90 | 1.79 | 1.84 | 653,023 |
| 28/04/26 | 1.89 | 2.005 | 1.85 | 1.85 | 1,330,004 |
| 27/04/26 | 1.78 | 1.935 | 1.75 | 1.89 | 1,022,138 |
| 24/04/26 | 1.73 | 1.82 | 1.73 | 1.74 | 856,181 |
| 23/04/26 | 1.82 | 1.8393 | 1.7301 | 1.81 | 1,119,084 |
| 22/04/26 | 1.89 | 1.9099 | 1.81 | 1.84 | 810,867 |
| 21/04/26 | 1.90 | 1.97 | 1.85 | 1.86 | 901,886 |
|
|
||||
|
|
||||
|
|